Comment on "Can NPC1L1 inhibitors reduce the risk of biliary tract cancer? Evidence from a Mendelian randomization

Rui Chen1, Fayuan Wang1, WuSheng Li2

  • 1College of Integrative of Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan, China, 646000; The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China, 646000.

Abstract

No abstract available in PubMed .

Related Concept Videos